학술논문
Ibrutinib Plus Bendamustine Plus Rituximab and Rituximab Maintenance (I plus BR) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Regimen (R-CHOP) and Rituximab, Cyclophosphamide, Doxorubicin, Bortezomib, Prednisone Regimen (VR-CAP) in First-Line Mantle Cell Lymphoma Patients: An Adjusted Treatment Comparison Using Inverse Probability Weighting
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020